SCHEMBL201737

SCHEMBL201737

[CH2]C(C)S(=O)(=O)CCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.47
TP53 P04637 2/20 0.39
NPC1 O15118 1/20 0.39
S1PR2 O95136 1/20 0.39
S1PR4 O95977 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
AGTR1 P30556 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FAAH O00519 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10585886 0.91 CA2 (0.59) CA2TP53FAAHCES1
SCHEMBL11454291 0.91 CA2 (0.59) CA2TP53FAAHCES1
SCHEMBL201100 0.84
SCHEMBL2305626 0.79 CA2 (0.50) CA2TP53NPC1S1PR2S1PR4
SCHEMBL27996571 0.78 CA2 (0.45) CA2TP53NPC1S1PR2S1PR4
SCHEMBL4259130 0.78 CA2 (0.36) CA2
SCHEMBL3105085 0.77 CA2 (0.48) CA2TP53NPC1S1PR2S1PR4
SCHEMBL5199514 0.75
SCHEMBL198766 0.75
SCHEMBL2306255 0.75 CA2 (0.47) CA2TP53NPC1S1PR2S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8344142-B2 perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes GEORGIA TECH RESEARCH CORPORATION (US) 2013-01-01 US claimed
US-8039625-B2 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-18 US claimed
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF NATIONAL SCIENCE FOUNDATION 2009-02-19 US claimed
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof GEORGIA TECH RESEARCH CORPORATION 2008-09-18 US claimed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 WO claimed
WO-2005124453-A2 PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO claimed
CN-115175967-B Ionic liquids for stabilizing viscosity of silicate-based coatings 巴斯夫欧洲公司 2024-06-14 CN disclosed
US-20230042328-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2023-02-09 US disclosed
CN-115175967-A Ionic liquids for stabilizing viscosity of silicate-based coatings 巴斯夫欧洲公司 2022-10-11 CN disclosed
WO-2021122673-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2021-06-24 WO disclosed
EP-3134380-B1 METHOD FOR PRODUCING CARBOXYLIC ACID ESTERS IN THE PRESENCE OF AN IONIC LIQUID AND AN ACIDIC ESTERIFICATION CATALYST AND THE USE THEREOF AS PLASTICIZER BASF SE (DE) 2019-08-14 EP disclosed
US-9776949-B2 Process for the production of carboxylic esters and use of these as plasticizers BASF SE (DE) 2017-10-03 US disclosed
EP-3134380-A1 METHOD FOR PRODUCING CARBOXYLIC ACID ESTERS IN THE PRESENCE OF AN IONIC LIQUID AND AN ACIDIC ESTERIFICATION CATALYST AND THE USE THEREOF AS PLASTICIZER BASF SE (DE) 2017-03-01 EP disclosed
WO-2008119770-A1 METHOD FOR MODIFYING THE STRUCTURE OF A CELLULOSE MATERIAL BY TREATMENT WITH AN IONIC LIQUID BASF SE (DE) 2008-10-09 WO disclosed
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof GEORGIA TECH RESEARCH CORPORATION 2008-09-18 US disclosed
WO-2008090155-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT CAN BE PRETREATED WITH AN IONIC LIQUID CONTAINING A POLYATOMIC ANION BASF SE (DE) 2008-07-31 WO disclosed
WO-2008090156-A1 METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION BASF SE (DE) 2008-07-31 WO disclosed
WO-2007138051-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2007-12-06 WO disclosed
WO-2006093965-A2 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2006-09-08 WO disclosed
WO-2005124453-A2 PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080223444-A1 Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof SLC43A1, SLC3A2, SLC16A3 CA2 766/4885TP53 2921/4885NPC1 596/4885
US-20090044863-A1 CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF SLC18A3, CORO1C, SLC18A1 CA2 741/4885TP53 1745/4885NPC1 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.